News | Heart Failure | June 18, 2024

JACC Report Card Highlights Inequities in CV Care, Death Rates

Despite significant advances in prevention and treatment, Black Americans have higher risk of cardiovascular death

Despite significant advances in prevention and treatment, Black Americans have higher risk of cardiovascular death

Getty Images


June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has published “Excess Cardiovascular Mortality Among Black Americans 2000-2022: A Report Card,” to highlight the persistent and tragic inequities in cardiovascular care and put in human terms the years of life lost to the Black community because of their higher cardiovascular disease death rates.

JACC Incoming Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, said, the goal of the report card is to promote accountability and catalyze action that finally addresses this national tragedy.

“Our study reveals that Black Americans, because of their higher cardiovascular mortality rates compared with White Americans, have suffered almost 800,000 excess deaths, which translates to about 24 million additional years of life lost between 2000 and 2022,” Krumholz, who is also senior author of the study and the Harold H. Hines, Jr. Professor of Medicine at Yale School of Medicine said. “This staggering figure highlights the critical need for systemic changes in addressing cardiovascular inequities.”

In an accompanying editorial, Jennifer H. Mieres, MD, FACC, chair of the ACC Diversity and Inclusion Committee and Senior Vice President, Center for Equity of Care, at Northwell Health in New Hyde Park, New York, said the report card serves as a reminder that all Americans have not benefited equally from significant advances made in the treatment and prevention of cardiovascular diseases.

“We are reminded of the stark reality that Black Americans continue to face significant disparities in cardiovascular outcomes,” Mieres said. “Bringing an equity lens to the redesign of CV health by addressing the social determinants of health and the systemic barriers that contribute to structural racism are critical for solving for cardiovascular health disparities and ensuring equity of care.”

Social determinants of health have a detrimental impact in creating barriers that prevent the most vulnerable Americans from receiving the cardiovascular care they need. The ACC has established multiple programs to address these inequities. The Internal Medicine Program introduces groups who have been historically underrepresented in cardiology to a career in cardiology by connecting them with the mentors, peer network and resources they need to understand career opportunities in the field and be better prepared to address the unique and diverse health care challenges their patients face.

The Clinical Trials Research (CTR) program is intended to increase the number of individuals historically underrepresented in cardiology who serve as leaders in cardiovascular clinical trials research to ensure diversity of thought, experience and perspective, and ensure that the evidence base includes data more closely reflecting the demographics of actual cardiovascular patients.

For more information: www.acc.org/About-ACC/Diversity-and-Inclusion.


Related Content

News | ACC

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

Home July 10, 2024
Home
News | ACC

May 9, 2024 — The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new ...

Home May 09, 2024
Home
News | ACC

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
News | ACC

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

Home April 06, 2024
Home
Feature | ACC | Christine Book

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

Home April 03, 2024
Home
News | ACC

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...

Home March 26, 2024
Home
Feature | ACC | By Melinda Taschetta-Millane

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...

Home March 25, 2024
Home
News | ACC

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...

Home March 21, 2024
Home
News | ACC

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

Home March 07, 2024
Home
News | ACC

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

Home February 29, 2024
Home
Subscribe Now